Medpace Holdings, Inc. MEDP
618.88
(1.71)
(0.28%)
as of 25 Sep
- Market cap
- $17.3B
- P/E
- 35.6×
Follow MEDP
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 162.15% | 77.25% | 70.23% | 73.71% |
+8 more TTM periods Free account |
|
| 27.09% | 22.87% | 22.13% | 22.57% | ||
ROIC |
0.00% | 0.00% | 0.00% | 3,822.71% | |
Return on Tangible Assets |
(215.54%) | (663.29%) | (202.23%) | (104.74%) | |
Average Days of Receivables |
57.96 | 53.77 | 58.00 | 57.73 | |
Free Cash Flow per Share |
25.08 | 25.00 | 23.64 | 24.05 | |
Free Cash Flow |
706.69 | 711.00 | 681.87 | 676.77 | |
Capital Expenditures |
(45.97) | (28.18) | (31.36) | (34.46) | |
Piotroski F-Score |
7.00 | 7.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
80.37% | 59.09% | 74.60% | 122.84% | |
Accounts Receivable Turnover |
6.79 | 7.73 | 7.24 | 6.89 | |
Accounts Payable Turnover |
19.04 | 15.72 | 24.13 | 27.22 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
17.80 | 16.70 | 14.03 | 13.49 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.18) | (0.19) | (0.17) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.79% | 7.00% | 7.81% | 8.40% | |
Share Based Compensation of Revenue |
0.76% | 0.85% | 1.37% | 1.49% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.53 | 1.61 | 1.58 | 1.64 | |
Depreciation/Fixed assets |
0.18 | 0.21 | 0.21 | 0.21 | |
Capex/Depreciation |
(1.65) | (1.00) | (1.11) | (1.21) | |
Revenue per Share |
98.75 | 94.16 | 87.72 | 83.82 | |
Operating CF per Share |
26.71 | 25.99 | 24.73 | 25.28 | |
Capex per Share |
(1.63) | (0.99) | (1.09) | (1.22) | |
Capex to Sales |
0.02 | 0.01 | 0.01 | 0.01 | |
Net Profit Margin |
17.67% | 17.19% | 17.83% | 18.36% |
Columns are period end dates